Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer [Phase 2]
This Phase 2 trial assessed the safety and efficacy of bevacizumab in combination with vinorelbine and trastuzumab for HER2-positive metasta…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood [Phase 2]
Phase 2 trial evaluating carboplatin/paclitaxel with pegfilgrastim supported by hematopoietic progenitor cell re-infusion in whole blood in …
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluates DLBS1425 as neoadjuvant therapy for stage II or III breast cancer, assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 study of capecitabine (Xeloda) in locally advanced or metastatic breast cancer has completed and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
This entry reports the completion of a clinical trial evaluating molecular breast imaging to assess tumor response to neoadjuvant therapy in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer [Phase 2]
Phase 2 trial evaluating preoperative dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with bevacizumab in operable breast…
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer [Phase 3]
A Phase 3 trial evaluating the addition of efaproxiral (RSR13) to whole-brain radiation therapy with oxygen in women with brain metastases f…
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Relaxation and Visualization Therapy for Breast Cancer Patients [NA]
The clinical trial examining relaxation and visualization therapy for breast cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy [Phase 3]
This Phase 3 trial evaluated pegfilgrastim as supportive therapy for neutropenia in patients with advanced breast cancer undergoing chemothe…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating letrozole plus either goserelin or leuprolide in premenopausal women with estrogen receptor-positive stage IV breas…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors [Phase 2]
Phase 2 trial evaluating high-dose chemotherapy with total-body irradiation followed by autologous stem cell or bone marrow transplantation …
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy [NA]
A randomized trial comparing full-dose intraoperative radiotherapy to external radiotherapy for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection [Phase 2]
Phase 2 trial investigating canine scent detection to distinguish lung cancer from gynecological cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms [NA]
A completed study evaluating escalating doses of tamoxifen in breast cancer patients with CYP2D6 polymorphisms.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer [Phase 1]
This update reports results from a Phase 1 trial evaluating sulindac for preventing breast cancer in women at high risk.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer
The trial evaluating diffuse optical tomography to monitor response to neoadjuvant chemotherapy in breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression [Phase 2]
Phase 2 trial evaluating the corrected QT interval effects of trastuzumab emtansine (T-DM1) and the safety/tolerability of combining T-DM1 w…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer [Phase 1]
Phase 1 trial evaluating Yttrium-90 SMT-487 in patients with refractory or recurrent cancers across multiple tumor types; the study has comp…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating radiolabeled SMT-487 (Yttrium-90-DOTA-Tyr3-octreotide) in patients with refractory small cell lung cancer or metast…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors
A clinical trial examining weight loss counseling for African American women who are breast cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect [Phase 1, Phase 2]
Phase I/II clinical trial updating escalating-dose melphalan with autologous stem cell support and amifostine cytoprotection across multiple…
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients [Phase 3]
Phase 3 trial of a sustained release methylphenidate for fatigue in cancer patients was terminated; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Individualized Risk-Based Education in Promoting Breast Cancer Screening in Healthy Women [NA]
This clinical trial update reports the completion of a study evaluating individualized, risk-based education to promote breast cancer screen…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing trastuzumab emtansine (T-DM1) versus capecitabine plus lapatinib in HER2-positive locally advanced or metastatic bre…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial of Trastuzumab-Mcc-DM1 in HER2-positive metastatic breast cancer completed with results posted in 2013.